Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Anticancer Res. 2010 Mar;30(3):915-21.
The aim of this study was to establish drug-resistant cell lines and to elucidate mechanisms leading to multi-drug resistance in gastric cancer.
Five cancer cell lines resistant to 5-fluorouracil, paclitaxel, oxaliplatin, irinotecan, or gemcitabine, were respectively established from a parent gastric cancer cell line, OCUM-2M, by stepwise exposure to each chemotherapeutical agent.
Cell death by apoptosis induced by anti-cancer drugs was low in 5 chemo-resistant cell lines. Percentage of cells in S and G(0)/G(1) phase was low in cell lines resistant to oxaliplatin or irinotecan. Cell lines resistant to paclitaxel, oxaliplatin, and gemcitabine showed multi-drug resistance. Alterations in MRP, DAPK1, or DAPK2 expression were found in multi-drug resistant cell lines.
The cell-cycle distribution and alterations of MRP, DAPK1, and DAPK2 genes may be integral part of mechanisms responsible for chemo-resistance. These cell lines might be useful to study molecular mechanisms leading to multi-drug resistance.
本研究旨在建立耐药细胞系,并阐明导致胃癌多药耐药的机制。
从胃癌亲本细胞系 OCUM-2M 中,通过逐步暴露于每种化疗药物,分别建立了对 5-氟尿嘧啶、紫杉醇、奥沙利铂、伊立替康或吉西他滨耐药的 5 株癌细胞系。
5 株耐药细胞系中抗癌药物诱导的细胞凋亡率较低。对奥沙利铂或伊立替康耐药的细胞系中 S 和 G(0)/G(1)期细胞比例较低。对紫杉醇、奥沙利铂和吉西他滨耐药的细胞系表现出多药耐药性。在多药耐药细胞系中发现了 MRP、DAPK1 或 DAPK2 表达的改变。
细胞周期分布和 MRP、DAPK1 和 DAPK2 基因的改变可能是导致化疗耐药的机制的重要组成部分。这些细胞系可能有助于研究导致多药耐药的分子机制。